PNC Financial Services Group’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-8,735
| Closed | -$629K | – | 4301 |
|
|
2020
Q4 | $629K | Sell |
8,735
-301
| -3% | -$15.8K | ﹤0.01% | 1345 |
|
|
2020
Q3 | $411K | Buy |
9,036
+1,311
| +17% | +$54.8K | ﹤0.01% | 1461 |
|
|
2020
Q2 | $348K | Sell |
7,725
-2,291
| -23% | -$103K | ﹤0.01% | 1593 |
|
|
2020
Q1 | $385K | Buy |
10,016
+3,392
| +51% | +$156K | ﹤0.01% | 1441 |
|
|
2019
Q4 | $307K | Buy |
6,624
+5,530
| +505% | +$239K | ﹤0.01% | 1794 |
|
|
2019
Q3 | $43K | Sell |
1,094
-734
| -40% | -$31.7K | ﹤0.01% | 3003 |
|
|
2019
Q2 | $89K | Sell |
1,828
-76
| -4% | -$4K | ﹤0.01% | 2610 |
|
|
2019
Q1 | $119K | Buy |
1,904
+9
| +0.5% | +$618 | ﹤0.01% | 2456 |
|
|
2018
Q4 | $114K | Buy |
1,895
+794
| +72% | +$47.7K | ﹤0.01% | 2384 |
|
|
2018
Q3 | $71K | Sell |
1,101
-138
| -11% | -$7.7K | ﹤0.01% | 2798 |
|
|
2018
Q2 | $56K | Sell |
1,239
-197
| -14% | -$7.86K | ﹤0.01% | 2919 |
|
|
2018
Q1 | $45K | Buy |
1,436
+37
| +3% | +$1.22K | ﹤0.01% | 3037 |
|
|
2017
Q4 | $42K | Sell |
1,399
-36
| -3% | -$1.04K | ﹤0.01% | 3045 |
|
|
2017
Q3 | $47K | Sell |
1,435
-193
| -12% | -$6.68K | ﹤0.01% | 2974 |
|
|
2017
Q2 | $54K | Sell |
1,628
-633
| -28% | -$18.9K | ﹤0.01% | 2863 |
|
|
2017
Q1 | $65K | Buy |
+2,261
| New | +$56K | ﹤0.01% | 2763 |
|
|
2013
Q4 | – | Sell |
-42
| Closed | – | – | 3830 |
|
|
2013
Q3 | $0 | Buy |
+42
| New | +$331 | ﹤0.01% | 3738 |
|
Other funds holding BEAT
PNC Financial Services Group's BEAT Position: Q1 2021 in Review
PNC Financial Services Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 8,735 shares — an estimated $629K sold.
PNC Financial Services Group first reported a position in BEAT in Q3 2013 and held it in 17 quarters. The position peaked at $629K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- PNC Financial Services Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- PNC Financial Services Group sold 8,735 BioTelemetry, Inc. shares in Q1 2021, an estimated $629K.
- PNC Financial Services Group first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 17 quarters.
- PNC Financial Services Group's BioTelemetry, Inc. position peaked at $629K in Q4 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on PNC Financial Services Group's 13F filing for Q1 2021, filed 7 May 2021.